caus
becom
global
pandem
highli
effect
medicin
vaccin
patient
recov
immun
respons
especi
viru
specif
igg
igm
respons
howev
igg
igm
respons
bare
known
enabl
global
understand
specif
igg
igm
respons
proteom
microarray
predict
protein
construct
microarray
appli
profil
igg
igm
respons
convalesc
sera
result
suggest
convalesc
phase
patient
igg
igm
respons
especi
protein
n
purifi
mammalian
cell
demonstr
highest
perform
differenti
patient
control
besid
protein
n
signific
antibodi
respons
also
identifi
indepth
analysi
show
level
igg
posit
correl
age
level
ldh
lactat
dehydrogenas
especi
women
level
igg
neg
correl
ly
lymphocyt
percentag
studi
present
first
whole
pictur
specif
igg
igm
respons
provid
insight
develop
precis
immunodiagnost
effect
treatment
vaccin
caus
coronaviru
china
alon
mar
diagnos
case
infect
death
accord
chines
cdc
http
global
diagnos
case
report
observ
treat
patient
convalesc
plasma
collect
patient
howev
newli
occur
pathogen
iggigm
respons
bare
known
mani
import
question
need
experiment
address
variat
among
differ
patient
especi
antibodi
nucleocapsid
protein
protein
n
spike
protein
protein
besid
nucleocapsid
protein
spike
protein
viral
protein
could
trigger
signific
antibodi
respons
least
patient
possibl
link
intens
overal
iggigm
respons
sever
patient
etc
urgent
need
answer
question
especi
systemat
manner
question
answer
least
touch
may
understand
iggigm
respons
detail
turn
facilit
us
develop
effect
treatment
therapeut
antibodi
protect
vaccin
tradit
techniqu
studi
igg
igm
respons
includ
elisa
immunecolloid
gold
strip
assay
howev
techniqu
usual
test
one
target
protein
one
antibodi
one
reaction
thu
power
tool
need
enabl
studi
igg
igm
respons
system
level
featur
capabl
highthroughput
parallel
analysi
miniatur
size
protein
microarray
may
choic
systemat
studi
stimul
iggigm
respons
varieti
protein
microarray
alreadi
construct
success
appli
serum
antibodi
profil
mtb
proteom
microarray
sarscov
protein
microarray
dengu
viru
protein
microarray
present
proteom
microarray
develop
use
ecoli
express
system
protein
collect
sever
commerci
sourc
convalesc
sera
analyz
microarray
first
overal
pictur
specif
igg
igm
respons
reveal
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
genom
kb
predict
encod
protein
ie
structur
protein
split
protein
accessori
protein
nonstructur
protein
nsp
fig
sequenc
protein
receptor
bind
domain
rbd
codon
optim
gene
synthes
clone
appropri
vector
express
e
coli
affin
purifi
protein
meanwhil
collect
recombin
protein
express
prokaryot
eukaryot
system
sourc
qualiti
control
protein
print
appropri
substrat
slide
convalesc
sera
collect
analyz
proteom
microarray
global
specif
igg
igm
respons
reveal
prepar
recombin
protein
microarray
fabric
first
determin
amino
acid
sequenc
predict
protein
follow
refer
genom
genbank
access
obtain
precis
analysi
split
protein
also
includ
rbd
critic
role
entri
cell
protein
sequenc
subject
codon
optim
clone
ecoli
express
vector
final
express
librari
includ
clone
tabl
sever
round
optim
far
manag
purifi
protein
fig
demonstr
western
blot
antibodi
coomassi
stain
protein
show
clear
band
expect
size
kda
good
puriti
meanwhil
order
cover
proteom
complet
possibl
take
posttransl
modif
ptm
especi
glycosyl
account
also
collect
recombin
protein
prepar
use
yeast
cellfre
system
mammalian
cell
express
system
varieti
sourc
figur
among
collect
protein
sever
differ
version
n
protein
tabl
final
obtain
protein
differ
version
differ
sourc
cover
predict
protein
protein
suitabl
microarray
construct
term
concentr
puriti
total
protein
along
posit
neg
control
print
microarray
slide
fig
sinc
protein
tag
tag
overal
qualiti
microarray
evalu
probe
antibodi
antibodi
result
show
protein
nice
immobil
microarray
qualiti
fairli
good
detail
layout
proteom
microarray
indic
well
fig
high
antibodi
respons
usual
observ
patient
control
sera
fig
sinc
fc
tag
could
recogn
fluoresc
label
antihuman
igg
antibodi
gener
high
signal
test
could
serv
control
antihuman
igg
antibodi
though
initi
reason
includ
microarray
applic
serum
profil
test
experiment
reproduc
serum
profil
use
microarray
two
convalesc
sera
random
select
three
independ
analysi
two
sera
repeat
microarray
pearson
correl
coeffici
two
repeat
igg
igm
respect
overal
fluoresc
intens
rang
repeat
experi
fairli
close
demonstr
high
reproduc
microarray
base
serum
profil
igg
igm
fig
ce
global
profil
antibodi
respons
protein
serum
patient
screen
sera
convalesc
patient
along
control
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
proteom
microarray
patient
hospit
foshan
fourth
hospit
china
variabl
stay
time
inform
patient
summar
tabl
serum
patient
collect
day
hospit
discharg
standard
criteria
met
recurr
report
patient
sampl
control
probe
proteom
microarray
data
filter
normal
built
igg
igm
profil
serum
perform
cluster
analysi
gener
heatmap
overal
visual
fig
fig
patient
control
perfectli
cluster
igg
igm
justifi
util
proteom
microarray
viru
specif
antibodi
analysi
expect
n
protein
protein
elicit
high
antibodi
respons
almost
patient
bare
control
group
confirm
efficaci
two
protein
diagnosi
interestingli
also
found
case
protein
n
gener
significantli
higher
signal
compar
control
group
sinc
n
protein
wide
use
antigen
diagnosi
next
character
serum
antibodi
respons
two
protein
present
cohort
n
protein
except
prove
excel
discrimin
abil
patient
control
igg
igm
fig
b
fig
b
overal
igg
signal
intens
much
higher
igm
mainli
sera
collect
convalesc
stage
igg
suppos
domin
notabl
two
sera
control
group
significantli
higher
igg
antibodi
respons
n
protein
control
one
nnter
anoth
cnter
fig
suggest
n
protein
may
gener
higher
fals
posit
rate
protein
especi
investig
consist
signal
intens
among
differ
sourc
version
cterm
nterm
domain
fragment
protein
calcul
pearson
correl
coeffici
among
protein
fig
n
protein
fig
use
data
convalesc
sera
high
correl
observ
among
differ
concentr
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
protein
protein
differ
sourc
also
high
correl
fig
h
fig
b
c
g
although
n
protein
high
concentr
gener
almost
satur
signal
fig
special
full
length
protein
differ
sourc
either
obtain
ecoli
express
system
high
correl
observ
fig
indic
protein
differ
sourc
good
perform
detect
howev
background
signal
control
group
much
lower
protein
purifi
mammalian
cell
ie
fig
suggest
may
possess
higher
septic
could
serv
better
reagent
develop
immunediagnost
signal
full
length
protein
highli
correl
srbd
fig
much
stronger
signal
contrast
correl
level
region
fulllength
rbd
lower
fig
fig
addit
signal
poorli
correl
protein
fig
data
may
reflect
differ
immunogen
differ
region
protein
epitop
map
could
answer
question
similar
situat
also
observ
n
protein
fig
fig
interestingli
moder
signific
liner
correl
observ
igg
respons
n
fig
addit
correl
igg
igm
signal
protein
low
fig
k
may
inpart
overal
igm
signal
much
lower
igg
fig
convalesc
stage
proteom
microarray
enabl
us
investig
antibodi
respons
predict
protein
includ
n
protein
mention
protein
n
protein
also
gener
high
igg
signal
fig
global
analysi
identifi
protein
high
igg
respons
detect
least
one
convalesc
sera
fig
importantli
patient
present
posit
igg
antibodi
threshold
set
base
signal
control
sera
fig
igg
antibodi
posit
patient
posit
control
sera
fig
investig
igg
respons
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
depend
igg
respons
n
protein
calcul
correl
among
turn
obviou
correl
igg
igg
n
fig
e
suggest
two
protein
may
provid
complementari
inform
either
diagnosi
worth
studi
explor
specif
immun
respons
known
immun
respons
close
relat
diseas
cours
evalu
relationship
antibodi
respons
situat
diseas
investig
correl
igg
igm
respons
protein
viru
clinic
characterist
surprisingli
day
onset
correl
igg
respons
fig
n
protein
date
shown
igg
respons
usual
increas
time
reach
peak
sever
week
onset
observ
studi
sar
patient
contrast
correl
igm
respons
day
onset
observ
age
also
correl
igg
respons
n
protein
fig
fig
three
patient
mild
symptom
indic
red
arrow
show
low
igg
respons
highli
variabl
patient
common
symptom
notabl
male
patient
especi
older
correl
age
igg
poor
fig
investig
phenomenon
separ
analyz
male
femal
patient
differ
age
group
femal
older
year
old
igg
respons
significantli
stronger
either
group
femal
younger
male
counterpart
fig
male
younger
high
correl
age
n
igg
respons
observ
fig
fig
correl
caus
day
onset
fig
femal
whatev
age
rang
igg
respons
n
highli
correl
age
fig
e
exclud
influenc
day
onset
patient
similar
day
onset
select
fig
high
correl
still
observ
fig
fig
demonstr
correl
independ
day
onset
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
found
igg
respons
n
protein
highli
correl
peak
lactat
dehydrogenas
ldh
level
femal
fig
significantli
male
patient
fig
evalu
whether
correl
peak
ldh
viru
specif
igg
respons
femal
patient
patient
day
onset
rang
age
select
form
smaller
cohort
statist
correl
age
day
onset
peak
ldh
observ
fig
turn
correl
still
high
signific
n
protein
specif
igg
respons
fig
fig
demonstr
correl
independ
age
day
onset
sinc
ldh
level
could
serv
indic
diseas
sever
seem
immun
system
women
may
sensit
viru
also
found
igg
respons
n
protein
neg
correl
percentag
lymphocyt
ly
fig
fig
howev
correl
might
depend
age
fig
protein
sequenc
download
genbank
access
number
accord
optim
genet
algorithm
amino
acid
sequenc
convert
ecoli
codonoptim
gene
sequenc
subsequ
sequenc
optim
gene
synthes
sangon
biotech
shanghai
china
synthes
gene
clone
transform
e
coli
strain
construct
transform
detail
inform
clone
construct
studi
given
tabl
recombin
protein
express
e
coli
grow
cell
ml
lb
medium
protein
express
induc
addit
mm
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
iptg
incub
cell
overnight
purif
protein
cell
pellet
resuspend
lysi
buffer
contain
mm
trishcl
ph
mm
nacl
mm
imidazol
ph
lyse
highpressur
cell
cracker
unionbiotech
shanghai
chn
cell
lysat
centrifug
rpm
min
supernat
purifi
sepharos
bead
senhui
microspher
technolog
suzhou
chn
wash
lysi
buffer
elut
buffer
contain
mm
trishcl
ph
mm
nacl
mm
imidazol
ph
purif
gsttag
protein
cell
harvest
lyse
highpressur
cell
cracker
lysi
buffer
contain
mm
trishcl
ph
mm
nacl
mm
dtt
centrifug
supernat
incub
gstsepharos
bead
senhui
microspher
technolog
suzhou
chn
target
protein
wash
lysi
buffer
elut
mm
trishcl
ph
mm
nacl
mm
dtt
mm
glutathion
purifi
protein
analyz
sdspage
follow
western
blot
use
antihi
antibodi
merck
millipor
usa
coomassi
brilliant
blue
stain
recombin
protein
also
collect
commerci
sourc
detail
inform
recombin
protein
prepar
studi
given
tabl
protein
along
neg
bsa
posit
control
antihuman
igg
igm
antibodi
print
quadrupl
path
substrat
slide
grace
biolab
oregon
usa
gener
ident
array
x
subarray
format
use
super
marathon
printer
arrayjet
uk
protein
array
store
use
institut
ethic
review
committe
foshan
fourth
hospit
foshan
china
approv
studi
written
inform
consent
obtain
patient
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
hospit
receiv
treatment
foshan
forth
hospit
variabl
stay
time
tabl
serum
sampl
collect
patient
discharg
hospit
sera
control
group
lung
cancer
patient
healthi
control
collect
ruijin
hospit
shanghai
china
sera
store
use
rubber
gasket
mount
onto
slide
creat
individu
chamber
ident
subarray
microarray
use
serum
profil
describ
previous
minor
modif
briefli
array
store
warm
room
temperatur
signal
intens
defin
median
foreground
subtract
median
background
spot
averag
quadrupl
spot
protein
igg
igm
data
analyz
separ
process
data
spot
exclud
probabl
print
contamin
pearson
correl
coeffici
two
protein
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
indic
correspond
p
valu
calcul
spss
softwar
default
paramet
cluster
analysi
perform
pheatmap
packag
r
order
profil
specif
iggigm
respons
construct
proteom
microarray
predict
protein
knowledg
first
set
recov
sera
analyz
microarray
global
igg
igm
profil
obtain
simultan
dual
color
strategi
data
clearli
show
protein
n
suitabl
diagnost
purifi
mammalian
cell
may
possess
better
specif
signific
antibodi
respons
identifi
show
level
igg
posit
correl
age
level
ldh
neg
correl
ly
proteom
microarray
enabl
global
profil
viru
specif
antibodi
respons
also
provid
semiquantit
inform
adopt
dual
color
strategi
microarray
measur
igg
igm
simultan
convalesc
patient
test
studi
median
day
onset
found
overal
igg
respons
significantli
higher
igm
indic
patient
specif
igg
respons
domin
convalesc
phase
although
igm
level
might
reach
peak
similar
time
point
igg
accord
studi
sar
well
known
n
protein
domin
antigen
sarscov
elicit
igg
igm
antibodi
antibodi
respons
n
protein
usual
stronger
howev
found
two
control
sera
strong
igg
bind
observ
n
protein
specif
one
control
recogn
n
protein
n
termin
anoth
c
termin
mayb
due
high
conserv
n
protein
sequenc
across
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
coronaviru
speci
indic
awar
fals
posit
appli
n
protein
diagnosi
contrast
protein
demonstr
higher
specif
thu
ideal
choic
develop
immunediagnost
mayb
combin
n
protein
protein
also
compar
antibodi
respons
varieti
version
includ
full
length
rbd
domain
n
termin
c
termin
antibodi
respons
rbd
region
highli
correl
full
length
protein
weaker
signal
howev
correl
among
version
signific
suggest
domin
epitop
elicit
antibodi
might
differ
among
individu
studi
detail
epitop
map
might
give
us
clear
answer
studi
also
found
signific
presenc
igg
igm
case
case
predict
accessori
protein
exhibit
high
overal
sequenc
similar
sar
sarslik
cov
like
lipid
bind
protein
previou
studi
show
sar
suppress
innat
immun
target
mitochondria
two
previou
studi
found
antibodi
sar
present
sera
patient
recov
sar
studi
also
demonstr
potenti
antibodi
detect
convalesc
patient
also
highli
homolog
sar
ident
similar
homolog
protein
varieti
coronavirus
proven
impair
ifn
respons
studi
first
report
provid
experiment
evid
show
exist
specif
antibodi
convalesc
sinc
nonstructur
protein
theoret
present
infect
cell
virion
antibodi
potenti
appli
distinguish
patient
healthi
peopl
immun
inactiv
viru
analyz
correl
specif
igg
respons
clinic
characterist
well
expect
igg
respons
improv
time
within
one
two
month
onset
observ
signific
correl
igg
signal
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
day
onset
also
found
peak
ldh
highli
correl
igg
respons
especi
femal
patient
mani
studi
report
ldh
tend
higher
level
sever
patient
could
indic
sever
fact
observ
sar
patient
sever
sar
associ
robust
serolog
respons
similar
associ
confirm
patient
especi
femal
interestingli
observ
high
correl
age
igg
respons
femal
patient
male
patient
age
less
older
male
patient
impli
humor
respons
may
differ
gender
report
sever
case
significantli
frequent
age
patient
mortal
male
patient
higher
femal
reason
clear
base
observ
assum
situat
might
associ
immun
respons
howev
femal
patient
compar
male
patient
may
gener
humor
respons
effici
differ
consid
treatment
limit
current
proteom
microarray
firstli
due
difficulti
protein
express
purif
still
protein
miss
tri
obtain
protein
vigor
optim
sourc
interest
find
anticip
near
futur
miss
protein
secondli
protein
microarray
express
mammalian
cell
critic
posttransl
modif
glycosyl
absent
known
nglycosyl
site
protein
heavili
glycosyl
glycosyl
may
play
critic
role
antibodyantigen
recognit
prepar
protein
use
mammalian
cell
system
microarray
upgrad
protein
purifi
mammalian
cell
ptm
specif
iggigm
respons
may
could
elicit
thirdli
sampl
collect
singl
time
point
analyz
though
interest
find
believ
current
conclus
could
strengthen
includ
sampl
furthermor
longitudin
sampl
collect
differ
time
point
individu
diagnosi
even
cure
may
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
enabl
us
reveal
dynam
specif
iggigm
respons
data
may
could
link
sever
among
differ
patient
applic
proteom
microarray
limit
serum
profil
could
also
explor
hostpathogen
interact
drug
small
molecul
target
identif
antibodi
specif
assess
construct
procedur
could
easili
expand
microarray
pan
human
coronaviru
proteom
microarray
includ
two
sever
coronavirus
ie
merscov
well
four
known
mild
human
coronavirus
ie
cov
cov
cov
cov
appli
microarray
assess
immun
respons
coronaviru
system
level
possibl
crossreact
could
easili
judg
taken
togeth
construct
first
proteom
microarray
microarray
could
appli
varieti
applic
includ
limit
indepth
igg
igm
respons
profil
analysi
convalesc
sera
microarray
obtain
first
overal
pictur
specif
igg
igm
profil
believ
find
studi
shed
light
develop
precis
diagnost
kit
appropri
treatment
effect
vaccin
combat
global
crisi
face
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
venkataraman
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
sera
shown
group
inform
serum
number
ncp
novel
coronaviru
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
vs
c
vs
vs
e
f
pearson
correl
coeffici
matrix
igg
respons
among
n
protein
spot
repres
one
sampl
gi
correl
overal
igg
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
respons
among
differ
dilut
protein
nw
nnter
ncter
vs
n
protein
h
ncter
vs
nnter
figur
igm
antibodi
respons
n
protein
box
plot
igm
respons
protein
dot
indic
one
serum
sampl
either
patient
group
green
control
group
brown
mean
standard
deviat
group
indic
protein
label
red
overexpress
p
valu
calcul
test
p
p
ns
signific
b
box
plot
igm
respons
n
protein
c
pearson
correl
coeffici
matrix
igm
respons
among
protein
differ
version
differ
sourc
dh
correl
overal
igm
respons
among
protein
vs
rbd
e
vs
protein
f
differ
n
protein
g
n
vs
protein
h
spot
repres
one
sampl
igg
respons
age
either
femal
blue
male
pink
red
arrow
indic
patient
mild
symptom
other
common
symptom
c
igg
respons
group
differ
age
gender
p
valu
calcul
test
p
p
ns
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
signific
di
correl
igg
respons
age
male
age
age
femal
e
ldh
male
f
ldh
femal
g
ly
male
h
ly
femal
spot
indic
one
patient
correspond
group
e
patient
day
onset
select
g
femal
patient
day
onset
rang
age
respons
day
onset
red
arrow
indic
patient
mild
symptom
other
regular
symptom
bl
correl
specif
igg
n
specif
igg
day
onset
age
ldh
ly
differ
group
specif
day
onset
vs
age
male
age
b
n
protein
specif
igg
vs
age
male
age
c
protein
specif
igg
vs
age
femal
n
protein
specif
igg
vs
age
femal
e
day
onset
vs
age
femal
patient
day
onset
f
n
protein
specif
igg
vs
age
femal
patient
day
onset
g
protein
specif
igg
vs
ldh
femal
h
age
day
onset
vs
ldh
femal
patient
day
onset
rang
age
n
protein
specif
igg
vs
ldh
femal
patient
day
onset
rang
age
j
n
protein
specif
igg
vs
ly
femal
k
age
vs
ly
femal
l
f
g
patient
day
onset
select
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doiorg
figur
overal
specif
igg
profil
sera
protein
figur
overal
specif
igm
profil
sera
protein
figur
antibodi
respons
n
protein
